Here, we hypothesized that in GBM, CXCR4 antagonism works by blocking the TIC supportive effects of the PVN, and that in combination with VEGF antagonism, would exert superior anti-tumor effect by inhibiting PVN formation and function. Here, CXCR4 is linked to glioblastoma.